TOTELL

Market Access & Health Economics​

​

Market access and HEOR work in tandem to ensure patients have timely access to effective therapies at reasonable prices. On one hand, market access involves determining the pricing of the therapeutic and its long-term success. On the other hand, HEOR employs clinical and economic evidence to determine therapeutic value, analyzing factors such as the current healthcare landscape and patient needs through budget impact models and cost-effectiveness analyses.

​

Our consultants excel at developing comprehensive market access strategies, performing detailed health economic evaluations, and expertly navigating the intricate reimbursement landscape. They specialize in optimizing pricing models, demonstrating the clinical and economic value of your product to payers and healthcare providers, and securing favorable reimbursement terms. By leveraging their extensive expertise, you can ensure your product achieves broad market acceptance, commercial success, and long-term sustainability, ultimately improving patient outcomes and enhancing healthcare systems globally.